# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-ex...
Lake Street analyst Frank Takkinen maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $3 to $6.
Envoy Medical (NASDAQ:COCH) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.20)...
As of December 31, 2023 cash and cash equivalents were approximately $4.2 million.